stage

Country: Netherlands

ISS Bone Reinforcement

ISS Bone Reinforcement

location_on Switzerland

Overview Pitch Details The Team Documents

Please note:
Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. Investors are encouraged to review and evaluate the investments and determine at their own discretion, the appropriateness of making the particular investment. The information on this website is provided for informational purposes only, but we cannot guarantee that the information is accurate or complete. We strongly encourage investors to complete their own due diligence with licensed professionals, prior to making any investment and will not offer any legal or tax advice.

Short Summary

The ISS is a novel approach to bone reinforcement decreasing the risk of surgical screw loosening. Compared to other alternatives, the ISS rapidly and durably reinforces bone allowing surgeons to safely optimize screw stability in orthopaedic surgery.

Highlights

Functional system that has already been safely & effectively used in humans
Positive feedback from FDA on study and regulatory path
Successful FTO assessment for US and Europe
Final development of implantable polymer sleeve. Ready for FDA.
Dedicated and talented development team with relevant and deep expertise

Overview

Target	€5,100,000
Minimum	€45,000
Investment Raised	€425,000
Previous Rounds	€4,300,000
Stage	MVP/Finished Product
Investor Role	Monthly Involvement

Ask a question
Have a question?

Similar Projects

Centro Ortopédico Integra

location_onVenezuela

Construir centro medico de primera línea que pueda satisfacer las necesidades de pacientes con estudios y procedimientos médicos que no hay en la región y que son de alta demanda y rentabilidad.

Formado por personal medico especializado de gran renombre
Necesidad regional de centro medico con todos los servicios necesarios
Capacidad de bajo costo y manejo de volumen

€8,500,000

Total Required

€850,000

Min per Investor

Entac Medical Inc.

location_onSouth East, United States

Entac develops AI-driven acoustic wearables predicting patient adverse events, with its first launched device, PrevisEA, targeting an $8 billion market and a pipeline for multiple high-value healthcare sectors exceeding $20 billion.

PrevisEA Commitments: 5 hospitals systems (63 hospitals) $41M revenue oppy
In review: 6 systems (71 hospitals) - $39M opportunity. Commitment due
Engaged: 7 systems (120 hospitals) - $67M opportunity - Expected in 2025.

€1,700,000

Total Required

€45,000

Min per Investor